Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2025

Alternate Routes of Administering Diuretics that Bypass the Gut

Presenter: Andrew Ambrosy

October 28, 2025

Presentation TCT 2025

Congestion in Heart Failure: Limitations of Diuretic Therapies and the Need for Device-Based Approaches

Presenter: Daniel Burkhoff

October 28, 2025

Presentation TCT 2025

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

Presenter: Sheldon E. Litwin

October 27, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Daily News

People With Tricuspid Valve Disease Want More Information, Sooner

Yael L. Maxwell

July 17, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News ESC Heart Failure 2025

Cardiology Consults Tied to Better Outcomes in Patients With HF

Todd Neale

May 19, 2025

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Todd Neale

May 02, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Conference News ACC 2025

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

Michael O'Riordan

April 01, 2025

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Daily News

CV Screening, Care at UK Football Club Made Inroads Against HF

Caitlin E. Cox

March 07, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

Advertisement

Alternate Routes of Administering Diuretics that Bypass the Gut

Congestion in Heart Failure: Limitations of Diuretic Therapies and the Need for Device-Based Approaches

TCT 586: Diuretic Management in Patients Treated with Greater Splanchnic Nerve Ablation for HFpEF: REBALANCE-HF Randomized Trial

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

People With Tricuspid Valve Disease Want More Information, Sooner

TCTMD’s Top 10 Most Popular Stories for June 2025

FDA Approves Triple Therapy Polypill for High Blood Pressure

Cardiology Consults Tied to Better Outcomes in Patients With HF

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

CV Screening, Care at UK Football Club Made Inroads Against HF

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content